In the life sciences supply chain, maintaining strict temperature conditions to ensure consistent product quality and integrity remains a key challenge for enterprises. As the global cold chain is growing in complexity, there is an increasing need to capture environmental and product movement traceability data in real-time to reduce product and operational waste, satisfy the reporting requirements, and share data with key stakeholders. Too often, supply chain data is siloed, preventing mission-critical information from driving both day-to-day and strategic decisions.
Approximately $53 billion worth of global biopharma products are at risk of temperature excursions every year due to temperature excursions. Supply chain transparency, collaboration, and resilience are becoming increasingly important because the frequency, magnitude, and costs of disruptions are increasing. This trend is expected to continue.
Within the cold chain, problems typically happen at multiple handoff points. Today, temperature excursions account for nearly 80 percent of supply chain problems. Each lane of travel—air, road, rail, and sea—requires different types of handoff points and poses different risks.
Losses of temperature-controlled products often occur because cold chains have historically lacked real-time access to actionable data that enables accurate decision-making and documents the integrity of delivered cargo.
This problem is compounded by the nature of data collection for temperature-sensitive and perishable products: many siloed points along the supply chain lack connectivity, and data collected by condition-monitoring devices—while current when it is collected—is not always immediately available for review and analysis to assess and ensure the quality and safety of products at the end of the supply chain.
The lack of visibility has limited businesses to decision-making based on collecting data only at the endpoints of the product journey, and often only after degradation or waste has occurred.
The costs incurred from temperature excursions are not limited to the direct costs of the ruined product and the costs associated with replacing it. Supply chain waste also includes the operational costs associated with the reporting, root cause analysis, and corrective and preventive action (CAPA) taken after a temperature deviation occurs. These operational costs have been reported to range from $3,000 to $10,000 for each investigation, at a per-incident average of approximately $6,500. The product and operational costs are adding up to several tens of millions of dollars annually for a single enterprise.
Controlant's mission is to increase safety and reduce waste by digitally connecting the global cold chain. The pay-per-shipment Cold-Chain-as-a-Service (ChaaS) solution is threefold and includes access to Internet of Things (IoT) data loggers that collect and automatically send critical supply chain data to a fully validated and compliant, cloud-enabled software platform, and cost-reducing operational services.
The Controlant solutions empower those responsible for supply chain performance to stay abreast of critical metrics in real-time when their products are in-transit, addressing problems quickly when they arise. Data analytics provide enterprises with deeper insights to fuel decision-making and collaboration throughout their entire supply chain.
Controlant’s real-time supply chain monitoring solution delivers advanced analytics and comprehensive, end-to-end insights into supply chain operations, from suppliers, through manufacture, distribution, and the last-mile. These insights include location, environmental conditions, such as temperature, light, utilization, and anomaly detection. Data is automatically sent to the cloud, where shipment data can be viewed and shared on-demand. No gateways or manual USB upload are needed. The Controlant solution is approved for all lanes (air, road, sea), and is EASA, IATA, and FAA compliant.
Shipment information can be viewed in real-time through Controlant’s proprietary cloud software platform. Custom dashboards are tailored to customer preferences and key performance metrics and include trends and insights regarding their supply chain (origins, destination, routes, and sub-routes), partners (freight forwarders, airlines, packaging solutions), and external points of interest (cross-docks, harbors, airports, borders). Enterprises can benchmark their supply chain data with key industry data to identify risks and improvement areas. The Controlant cloud platform is validated and compliant for life sciences use cases and is compliant with 21 CFR Part 11 and GMP Annex 11.
Controlant will form a proactive partnership to identify inefficiencies, explore opportunities, manage logistics, and reduce costs.
Businesses cannot manage what they cannot measure. The same holds true in the pharmaceutical supply chain. Linking analytics to operations and ongoing measurement will be key to mitigating supply chain risk, driving continuous improvement, and driving better margins. Moving forward, collaboration and proactive partnerships will be necessary to share performance insights and reshape supply chain strategies to adapt to the ever-changing demands while achieving efficiency, ensuring quality and compliance, and implementing customer-centricity to ensure patient safety.
Controlant’s Cold-Chain-as-a-Service (ChaaS) solution provides a single source of supply chain truth in real-time. Customers are achieving improvements leading to an annualized value in the tens of millions of dollars. For more information, visit controlant.com.
The clinical trial market is in a state of flux; innovative therapies, working practices and startups are creating a landscape of constant churn. To navigate it, supply chain optimisation will be essential.
New technology is sometimes sluggish to penetrate the pharmaceutical industry. With an era of digital transformation promising to optimize pharmaceutical supply chains, how are companies learning to embrace the change?